TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 87.48%278.66M | ---- | 183.05%148.64M | ---- | 131.54%52.51M | ---- | -187.22%-166.5M | ---- | -44.58%190.9M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 47.74%-8.15M | ---- | -13.63%-15.59M | ---- | -32.53%-13.72M | ---- | 33.71%-10.35M | ---- | 36.94%-15.62M |
Attributable subsidiary (profit) loss | ---- | 83.21%-8.57M | ---- | -342.50%-51.07M | ---- | 53.27%-11.54M | ---- | 45.57%-24.7M | ---- | 69.44%-45.37M |
Impairment and provisions: | ---- | 57.45%66.25M | ---- | 472.99%42.08M | ---- | -94.19%7.34M | ---- | 105.93%126.32M | ---- | 747.81%61.34M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18.07M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.5M | ---- | ---- |
-Other impairments and provisions | ---- | 57.45%66.25M | ---- | 472.99%42.08M | ---- | -93.77%7.34M | ---- | 172.31%117.81M | ---- | 498.00%43.27M |
Revaluation surplus: | ---- | 105.52%29.14M | ---- | -33.41%14.18M | ---- | -23.62%21.29M | ---- | 424.68%27.88M | ---- | 30.40%-8.59M |
-Fair value of investment properties (increase) | ---- | 105.52%29.14M | ---- | -33.41%14.18M | ---- | -23.62%21.29M | ---- | 424.68%27.88M | ---- | 30.40%-8.59M |
Asset sale loss (gain): | ---- | -65.73%122K | ---- | -78.50%356K | ---- | 50.41%1.66M | ---- | 76.73%1.1M | ---- | 575.57%623K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -99.18%19K | ---- | --2.31M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -63.80%122K | ---- | 151.61%337K | ---- | -161.14%-653K | ---- | 198.43%1.07M | ---- | -728.24%-1.09M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.07%33K | ---- | --1.71M |
Depreciation and amortization: | ---- | 9.34%77.82M | ---- | -0.53%71.17M | ---- | 9.92%71.55M | ---- | 39.19%65.09M | ---- | -20.65%46.77M |
-Amortization of intangible assets | ---- | 8.25%15.22M | ---- | 6.33%14.06M | ---- | 7.72%13.22M | ---- | 743.37%12.27M | ---- | 117.81%1.46M |
Financial expense | ---- | 87.37%6.37M | ---- | 128.67%3.4M | ---- | -26.54%1.49M | ---- | 242.30%2.02M | ---- | -95.70%591K |
Special items | ---- | 32.34%-48.97M | ---- | -125.08%-72.38M | ---- | 41.41%-32.16M | ---- | -2,123.13%-54.89M | ---- | -106.39%-2.47M |
Operating profit before the change of operating capital | ---- | 178.92%392.66M | ---- | 43.04%140.78M | ---- | 389.19%98.42M | ---- | -114.92%-34.03M | ---- | -17.72%228.18M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -184.01%-1.06M | ---- | 293.38%1.26M | ---- | -118.86%-650K | ---- | -102.56%-297K | ---- | 361.94%11.61M |
Accounts receivable (increase)decrease | ---- | -21.68%-641.68M | ---- | -61.99%-527.35M | ---- | -699.84%-325.54M | ---- | 210.45%54.27M | ---- | 59.59%-49.14M |
Accounts payable increase (decrease) | ---- | 14.10%753.72M | ---- | 361.25%660.6M | ---- | 196.28%143.22M | ---- | -304.64%-148.76M | ---- | 12.41%72.69M |
prepayments (increase)decrease | ---- | -136.91%-179.74M | ---- | 10.38%-75.87M | ---- | -974.83%-84.65M | ---- | -57.21%-7.88M | ---- | -124.56%-5.01M |
Special items for working capital changes | ---- | -1,380.04%-75.55M | ---- | -97.77%5.9M | ---- | 15.34%264.84M | ---- | 7,302.39%229.62M | ---- | -91.98%3.1M |
Cash from business operations | ---- | 20.96%248.36M | ---- | 114.70%205.32M | ---- | 2.91%95.63M | ---- | -64.45%92.93M | ---- | -4.93%261.43M |
Other taxs | ---- | 53.22%-8.3M | ---- | -135.60%-17.74M | ---- | 14.85%-7.53M | ---- | -51.85%-8.84M | ---- | 61.48%-5.82M |
Special items of business | -26.02%-742.25M | ---- | -724.56%-588.99M | ---- | -45.11%-71.43M | ---- | 70.00%-49.22M | ---- | -50.66%-164.1M | ---- |
Net cash from operations | -26.02%-742.25M | 27.98%240.06M | -724.56%-588.99M | 112.91%187.58M | -45.11%-71.43M | 4.78%88.1M | 70.00%-49.22M | -67.10%84.08M | -50.66%-164.1M | -1.64%255.61M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -47.74%8.15M | ---- | 13.63%15.59M | ---- | 32.53%13.72M | ---- | -33.71%10.35M | ---- | -36.94%15.62M |
Dividend received - investment | ---- | ---- | ---- | -95.22%3.7M | ---- | -37.08%77.42M | ---- | 42.22%123.04M | ---- | 213.75%86.51M |
Loan receivable (increase) decrease | ---- | -854.30%-36.84M | ---- | 43.78%-3.86M | ---- | -829.09%-6.87M | ---- | 32.14%-739K | ---- | -231.05%-1.09M |
Decrease in deposits (increase) | ---- | -425.45%-3.26M | ---- | 108.88%1M | ---- | -679.56%-11.29M | ---- | -144.13%-1.45M | ---- | 136.87%3.28M |
Sale of fixed assets | ---- | 1,494.85%14.86M | ---- | -46.56%932K | ---- | -76.17%1.74M | ---- | 3.19%7.32M | ---- | 471.10%7.09M |
Purchase of fixed assets | ---- | 15.75%-26.81M | ---- | 15.27%-31.83M | ---- | -129.06%-37.56M | ---- | 10.55%-16.4M | ---- | 66.32%-18.33M |
Purchase of intangible assets | ---- | -206.04%-14.84M | ---- | ---4.85M | ---- | ---- | ---- | 70.57%-12.53M | ---- | ---42.57M |
Sale of subsidiaries | ---- | ---- | ---- | -28.81%25.44M | ---- | --35.74M | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---3.24M | ---- | ---- | ---- | ---- | ---- | --40.09M |
Cash on investment | ---- | ---220M | ---- | ---- | ---- | ---- | ---- | 97.02%-6.66M | ---- | -1,010.33%-223.59M |
Other items in the investment business | 98.14%-4.16M | ---- | -956.61%-222.91M | ---- | -129.80%-21.1M | --16.97M | 198.39%70.81M | ---- | -407.11%-71.97M | ---- |
Net cash from investment operations | 98.14%-4.16M | -9,731.69%-278.74M | -956.61%-222.91M | -96.78%2.89M | -129.80%-21.1M | -12.68%89.88M | 198.39%70.81M | 177.40%102.93M | -407.11%-71.97M | -182.10%-132.99M |
Net cash before financing | 8.07%-746.41M | -120.31%-38.69M | -777.47%-811.9M | 7.02%190.47M | -528.75%-92.53M | -4.83%177.98M | 109.14%21.58M | 52.52%187.02M | -176.14%-236.07M | -42.36%122.62M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | --159.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Refund | ---- | -6.82%-143.06M | ---- | -7,659.62%-133.93M | ---- | -3,096.30%-1.73M | ---- | 99.23%-54K | ---- | 74.29%-7M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --5.13M | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | -17.51%-3.99M | ---- | -128.67%-3.4M | ---- | 26.54%-1.49M | ---- | -242.30%-2.02M | ---- | ---591K |
Dividends paid - financing | ---- | ---20.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -59.39%-45.56M |
Absorb investment income | ---- | -44.94%980K | ---- | --1.78M | ---- | ---- | ---- | -87.05%3.41M | ---- | -1.32%26.37M |
Other items of the financing business | -89.03%10.72M | 15.51%149.42M | --97.74M | 4,075.50%129.36M | ---- | 7.91%3.1M | ---- | 102.16%2.87M | 101.50%332K | 79.50%-132.66M |
Net cash from financing operations | -89.03%10.72M | 495.37%110.85M | --97.74M | -126.60%-28.04M | ---- | -5.94%-12.37M | ---- | 93.01%-11.68M | 101.50%332K | 75.29%-167.09M |
Effect of rate | -250.65%-116K | 65.42%-831K | 11.59%77K | 30.77%-2.4M | -99.68%69K | -106.78%-3.47M | 254.21%21.75M | 476.88%51.21M | -2,430.91%-14.1M | 78.24%-13.59M |
Net Cash | -3.01%-735.69M | -55.57%72.17M | -671.84%-714.17M | -1.92%162.43M | -528.75%-92.53M | -5.55%165.61M | 109.15%21.58M | 494.30%175.34M | -119.05%-235.73M | 90.40%-44.47M |
Begining period cash | 5.98%1.26B | 15.49%1.19B | 15.49%1.19B | 18.62%1.03B | -0.05%1.03B | 7.91%871M | 28.07%1.03B | -6.71%807.13M | -6.71%807.13M | -37.80%865.18M |
Cash at the end | 10.36%528.7M | 5.98%1.26B | -49.07%479.08M | 15.49%1.19B | -12.66%940.68M | -0.05%1.03B | 93.26%1.08B | 28.07%1.03B | -26.50%557.29M | -6.71%807.13M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.